This inventor holds 3 USPTO granted patents and 1 published patent application. Top assignees: Medtronic Angiolink, Inc., Angiolink Corporation. Active years: 2003-2007.
Company Filing History:
Years Active: 2003-2007
Title: Innovations by Steve J Tallarida: Advanced Wound Site Management
Introduction
Steve J Tallarida, an accomplished inventor based in Mansfield, MA, has made significant contributions in the field of medical technology. With a total of three patented inventions, his latest innovations focus on advanced wound site management systems, showcasing his dedication to improving patient care and medical procedures.
Latest Patents
Tallarida's latest patents provide innovative solutions for managing wound sites more effectively. One notable patent outlines an introducer design that includes a sheath, a guide rod, and multiple wire stabilization guides. This introducer is engineered to stabilize the sheath in relation to the wound site through a retention device that expands outwardly. Additionally, the guide rod features blood marking lumens, which allow medical professionals to assess the depth of insertion into arteries or veins based on the detection of pressurized blood.
Another patent by Tallarida presents a similar introducer design, although this version utilizes a guide rod that can securely hold the wire stabilization guide through slots along its length. The wire stabilization guides are designed to exert an outward force on the wound site and can also form a loop for enhanced tissue support, ensuring that the sheath is centrally positioned over the wound.
Career Highlights
Steve J Tallarida has had a distinguished career within reputable companies in the medical field. He has worked with Medtronic and Angiolink, where he contributed to the development of innovative medical devices aimed at enhancing patient outcomes. His experiences at these firms reflect his focus on cutting-edge technology and patient-centered design.
Collaborations
Throughout his career, Tallarida has had the privilege of collaborating with esteemed colleagues, including Glenn Kanner and Kenneth Arden Eliasen. These partnerships have allowed him to leverage diverse expertise, fostering innovation and pushing the boundaries of medical technology.
Conclusion
Steve J Tallarida's innovative spirit and dedication to advancing medical technology are evident through his patents focused on wound site management. His contributions have the potential to significantly improve the efficiency and effectiveness of medical procedures, ultimately benefiting patient care. As he continues to innovate, the medical community eagerly anticipates his future developments.